Company / EPS (Basic)
Insulet Corporation EPS (Basic) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$2.96
FY2025
5-year range
$0.07 / $2.96
FY2021-FY2025
Trend
+4128.6%
vs FY2024
Sector context
#47 of 160
Health Care
What the data says
EPS (Basic) changed +4129% YoY in FY2025, a notable deviation from the 7-year average annual change of +639%.
Based on SEC 10-K filings.
2.96 in FY2025 with a 5-year CAGR of +118.1%.
Improved from $0.25 to $2.96 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +199.7%
- 5-Year CAGR
- +118.1%
- 10-Year CAGR
- -
Sector benchmark
#47 of 160 in Health CareTop 29% of 160This company $2.96 Sector average $1.66
▼
+78.7% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 4128.6% year-over-year.
- Ranks #47 out of 160 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.96 | +4128.6% |
| FY2024 | $0.07 | -72.0% |
| FY2023 | $0.25 | +127.3% |
| FY2022 | $0.11 | -42.1% |
| FY2021 | $0.19 | +216.7% |
| FY2020 | $0.06 | +113.0% |
| FY2019 | -$0.46 | +4.2% |
| FY2018 | -$0.48 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026